These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Pierce EA; Foley ED; Smith LE Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081 [TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. Hartnett ME Clin Perinatol; 2014 Dec; 41(4):925-43. PubMed ID: 25459781 [TBL] [Abstract][Full Text] [Related]
24. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Good WV; Hardy RJ; Dobson V; Palmer EA; Phelps DL; Quintos M; Tung B; Pediatrics; 2005 Jul; 116(1):15-23. PubMed ID: 15995025 [TBL] [Abstract][Full Text] [Related]
25. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register. Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A Br J Ophthalmol; 2016 Dec; 100(12):1656-1661. PubMed ID: 26969711 [TBL] [Abstract][Full Text] [Related]
26. [Vascular endothelial growth factor receptor--structure and function]. Liu L; Hu BC; Zhang YJ Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):269-72. PubMed ID: 12545721 [No Abstract] [Full Text] [Related]
27. [Retinopathy of prematurity: clinical findings and current opinions on diagnosis and treatment]. Modrzejewska M Ann Acad Med Stetin; 2006; 52(1):73-8; discussion 78. PubMed ID: 17131850 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor-mediator of PHSS? Kol S Fertil Steril; 2003 Jun; 79(6):1466; author reply 1466. PubMed ID: 12798905 [No Abstract] [Full Text] [Related]
30. Pathogenesis of retinopathy of prematurity. Smith LE Semin Neonatol; 2003 Dec; 8(6):469-73. PubMed ID: 15001119 [TBL] [Abstract][Full Text] [Related]
31. [Vascular endothelial growth factor and nitric oxide]. Liu YQ; Zhou AR Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):69-71. PubMed ID: 12532773 [No Abstract] [Full Text] [Related]
32. The molecular perspective: VEGF and angiogenesis. Goodsell DS Oncologist; 2002; 7(6):569-70. PubMed ID: 12490744 [No Abstract] [Full Text] [Related]
33. Screening examination of premature infants for retinopathy of prematurity. ; ; Pediatrics; 2006 Feb; 117(2):572-6. PubMed ID: 16452383 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Lashkari K; Hirose T; Yazdany J; McMeel JW; Kazlauskas A; Rahimi N Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359 [TBL] [Abstract][Full Text] [Related]
35. Retinopathy of prematurity: New developments bring concern and hope. Darlow BA J Paediatr Child Health; 2015 Aug; 51(8):765-70. PubMed ID: 25757043 [TBL] [Abstract][Full Text] [Related]
37. Retinopathy of prematurity. Aggarwal R; Agarwal R; Deorari AK; Paul VK Indian J Pediatr; 2002 Jan; 69(1):83-6. PubMed ID: 11876127 [TBL] [Abstract][Full Text] [Related]
38. [Retinopathy of prematurity--pathogenesis and prevalence]. Modrzejewska M Ann Acad Med Stetin; 2006; 52(1):67-72; discussion 72. PubMed ID: 17131849 [TBL] [Abstract][Full Text] [Related]
39. Lessons in retinopathy of prematurity from Shanghai. Quinn GE; Fielder AR; Azad R; Zhao P Clin Perinatol; 2013 Jun; 40(2):323-7. PubMed ID: 23719313 [TBL] [Abstract][Full Text] [Related]
40. Screening for retinopathy of prematurity in China: a neonatal units-based prospective study. Xu Y; Zhou X; Zhang Q; Ji X; Zhang Q; Zhu J; Chen C; Zhao P Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8229-36. PubMed ID: 24204053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]